Marketing-authorisation holder

Kite Pharma, Inc.

3 medicines2 countries

3 medicines in 2 countries, as authorisation holder and manufacturer.

Its medicines

Group structure

Part of

KITEPharmaceutical group

Other companies in the group

Netherlands1

Kite Pharma Eu B.V.

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine in the registers under its name, current ones first.

3 medicines

Medicine	Substance	Country	Status	Authorised
Tecartus210^6 CAR-positive viable T cells per kg body weight · For Injection	Brexucabtagene autoleucel	United States	Marketed	2020
Yescarta2 10^6 car-positive viable t cells per kg of body weight · Injection	Axicabtagene ciloleucel	United States	Marketed	2017
Yescarta	Axicabtagene ciloleucel	Saudi Arabia	Authorised

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Marketing-authorisation holder

Kite Pharma, Inc.

3 medicines2 countries

3 medicines in 2 countries, as authorisation holder and manufacturer.

Its medicines

Group structure

Part of

KITEPharmaceutical group

Other companies in the group

Netherlands1

Kite Pharma Eu B.V.

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine in the registers under its name, current ones first.

3 medicines

Medicine	Substance	Country	Status	Authorised
Tecartus210^6 CAR-positive viable T cells per kg body weight · For Injection	Brexucabtagene autoleucel	United States	Marketed	2020
Yescarta2 10^6 car-positive viable t cells per kg of body weight · Injection	Axicabtagene ciloleucel	United States	Marketed	2017
Yescarta	Axicabtagene ciloleucel	Saudi Arabia	Authorised

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	2	2	0	Companies All medicines
Saudi Arabia	1	1	0	Companies All medicines

Top substances

The active substances in most of its medicines.

Names in the registers

How the registers spell it, normalised: legal forms, accents and capitals removed.

kite
kite pharma inc

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Saudi Food and Drug Authority

Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.

Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions

Report an error or request removalCorrections from the company itself are welcome.

At a glance

Type: Marketing-authorisation holder
Group: KITE
Medicines: 3
Countries: 2
Roles: Authorisation holder and manufacturer

Group structure

Part of

Other companies in the group

🇳🇱Netherlands1

Medicines

Know your medicines, with the sources.

Group structure

Part of

Other companies in the group

🇳🇱Netherlands1

Medicines

Know your medicines, with the sources.

Countries

Top substances

Names in the registers

Sources and licences

At a glance

Netherlands1

Netherlands1